收录21个品种

Core Viewpoint - The fourth batch of encouraged generic drug list has been released, including 21 varieties and 47 specifications, focusing on patient treatment needs and addressing weak R&D areas in domestic companies [1] Group 1: Drug Categories - The new list includes drugs for oncology, nervous system, assisted reproduction, and radioactive diagnostics [1] - It prioritizes products with new targets and mechanisms of action, such as a drug for alleviating moderate to severe itching in chronic kidney disease patients undergoing dialysis [1] Group 2: Market Considerations - The list emphasizes the inclusion of products already recommended in international first-line guidelines, such as Suvorexant for treating insomnia, which addresses issues like difficulty falling asleep and excessive daytime sleepiness [1] - The selection process also considers the accessibility of medications while prioritizing products with existing clinical practices in China [1]